Retacrit [package insert]. In general, about 45% of nephrologists are accepting that Retacrit will be equivalent to Amgen's Epogen and Janssen's Procrit in terms of efficacy and safety, and about 60% report being . Aranesp, Epogen, Procrit, and Retacrit are proven when used to treat anemia in cancer chemotherapy when both of the following criteria are met: 1,4,5. o Hematocrit less than 30% at initiation of therapy; and o There is a minimum of two additional months of planned chemotherapy . a stroke. • Seizures: Aranesp increases the risk for seizures in patients with CKD (5.4). Do not use Aranesp that has been frozen. Aranesp ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis. Do not re-enter preservative-free vials. Aranesp, Epogen, Procrit, and Retacrit are proven and medically necessary to treat anemia associated with myelodysplastic syndromes when the following criteria are met: 2, 3,8,9,32,46 . Aranesp (Darbepoetin Alfa): Uses, Dosage, Side Effects ... - RxList IE browser is not currently supported | Pfizer for Professionals mircera to aranesp conversion Aranesp 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300, 500 micrograms solution for injection in pre-filled pen. Epoetin alfa (EPOGEN; Amgen Inc.) was used as the reference epoetin product. PDF RETACRIT Injection, Solution for Intravenous or ... - Pfizer pro (2005). RETACRIT™ Dosage and Administration (epoetin alfa-epbx) What is/was your patient's PRETREATMENT hemoglobin level (g/dL) [prior to use of epoetin (Aranesp, Epogen, Mircera, Procrit, Retacrit)]?
